Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Professional regulation for Australasian genetic counselors.

Authors:
Cass Hoskins Clara Gaff Alison McEwen Ivan Macciocca Amy Pearn Carolyn Shalhoub Hayley Salvemini Jennifer Berkman Kate E Riley Rachel Williams Michael Milward Mary-Anne Young

J Genet Couns 2020 Nov 5. Epub 2020 Nov 5.

Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.

As a result of the ongoing global expansion of genetic counseling, the need to formalize a system of professional regulation for genetic counselors was identified in Australasia. In June 2017, under the auspices of the Human Genetics Society of Australasia (HGSA), a working party was convened. The purpose of the working party was to provide strategic leadership for the profession of Australasian genetic counselors with a goal to formalize a national regulatory framework for genetic counselors across both Australian and New Zealand jurisdictions. This was ultimately achieved in Australia through full membership with the National Alliance of Self-Regulating Health Professions (NASRHP) while the profession of genetic counseling in New Zealand is utilizing this framework to establish their regulation pathway. Regulation has a number of implications for genetic counselors, their employers, and the wider community, with the primary purpose of regulation being protection of the public from harm. This paper details the process of formalizing self-regulation for genetic counselors in Australasia, by defining professional regulation; outlining the purpose of regulation and the status of regulation for genetic counselors in Australasia and internationally, as well as health professionals more broadly; exploring the challenges of establishing regulation in Australasia; and the next steps for regulation in Australasia. Through detailing this process, the intention is to provide a framework to support genetic counseling colleagues internationally as well as other health professions in Australasia to explore and achieve regulation through their respective jurisdiction.

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgc4.1344DOI Listing
November 2020

Publication Analysis

Top Keywords

genetic counselors
28
genetic counseling
12
professional regulation
12
genetic
10
regulation
10
regulation genetic
8
internationally well
8
counselors australasia
8
health professions
8
regulation australasia
8
working party
8
well health
8
australasian genetic
8
purpose regulation
8
counselors
7
australasia
7
full membership
4
australasia steps
4
membership national
4
national alliance
4

Altmetric Statistics


Show full details
6 Total Shares
6 Tweets
6 Citations

Similar Publications

First Somatic Defect Associated With Mosaicism for Another Mutation in a Patient With Cushing Syndrome.

Authors:
Crystal D C Kamilaris Fabio R Faucz Victoria C Andriessen Naris Nilubol Chyi-Chia Richard Lee Mark A Ahlman Fady Hannah-Shmouni Constantine A Stratakis

J Endocr Soc 2021 Apr 25;5(4):bvab007. Epub 2021 Jan 25.

Section on Endocrinology and Genetics (SEGEN), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), Bethesda, MD, USA.

Context: Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of ACTH-independent Cushing syndrome (CS) associated mostly with Carney complex (CNC), a rare autosomal dominant multiple neoplasia syndrome. More than two-thirds of familial cases and approximately one-third of sporadic cases of CNC harbor germline inactivating defects. Increasingly sensitive technologies for the detection of genetic defects such as next-generation sequencing (NGS) have further highlighted the importance of mosaicism in human disease. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Gene in Hereditary Non-syndromic Hearing Loss: Recurrence and Incomplete Penetrance of the p.C113Y Mutation in Northwest Africa.

Authors:
Chiara Chiereghin Michela Robusto Lucia Mauri Paola Primignani Pierangela Castorina Umberto Ambrosetti Stefano Duga Rosanna Asselta Giulia Soldà

Front Genet 2021 10;12:606630. Epub 2021 Feb 10.

Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy.

Inherited hearing loss is extremely heterogeneous both clinically and genetically. In addition, the spectrum of deafness-causing genetic variants differs greatly among geographical areas and ethnicities. The identification of the causal mutation in affected families allows early diagnosis, clinical follow-up, and genetic counseling. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?

Authors:
Marco Volante Ozgur Mete Giuseppe Pelosi Anja C Roden Ernst Jan M Speel Silvia Uccella

Endocr Pathol 2021 Feb 27. Epub 2021 Feb 27.

Dept. of Medicine and Surgery, University of Insubria, Varese, Italy.

Thoracic (pulmonary and thymic) neuroendocrine tumors are well-differentiated epithelial neuroendocrine neoplasms that are classified into typical and atypical carcinoid tumors based on mitotic index cut offs and presence or absence of necrosis. This classification scheme is of great prognostic value but designed for surgical specimens, only. Deep molecular characterization of thoracic neuroendocrine tumors highlighted their difference with neuroendocrine carcinomas. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Secondary Data Usage in Direct-to-Consumer Genetic Testing: To What Extent Are Customers Aware and Concerned?

Authors:
Janessa Mladucky Bonnie Baty Jeffrey Botkin Rebecca Anderson

Public Health Genomics 2021 Feb 26:1-8. Epub 2021 Feb 26.

Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.

Introduction: Customer data from direct-to-consumer genetic testing (DTC GT) are often used for secondary purposes beyond providing the customer with test results.

Objective: The goals of this study were to determine customer knowledge of secondary uses of data, to understand their perception of risks associated with these uses, and to determine the extent of customer concerns about privacy.

Methods: Twenty DTC GT customers were interviewed about their experiences. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Hope versus reality: Parent expectations of genomic testing.

Authors:
Katherine E Donohue Siobhan M Dolan Dana Watnick Katie M Gallagher Jacqueline A Odgis Sabrina A Suckiel Nehama Teitelman Bruce D Gelb Eimear E Kenny Melissa P Wasserstein Carol R Horowitz Laurie J Bauman

Patient Educ Couns 2021 Jan 29. Epub 2021 Jan 29.

Department of Pediatrics, Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, United States; Department of Psychiatry and Behavioral Sciences, Montefiore Medical Center / Albert Einstein College of Medicine, Bronx, NY, United States. Electronic address:

Objective: Genomics is increasingly used for diagnostic testing in children. This study describes the expectations of parents whose child received genomic testing and whether or not they were met.

Methods: A diverse stratified, purposive sample of parents of 22 children in New York City was interviewed using a semi-structured guide. Read More

View Article and Full-Text PDF
January 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap